Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Moodys
Express Scripts
AstraZeneca
Medtronic
Harvard Business School
Merck

Last Updated: November 19, 2019

DrugPatentWatch Database Preview

Litigation Details for SHIRE LLC v. MYLAN PHARMACEUTICALS, INC. (D.N.J. 2012)

See Plans and Pricing

« Back to Dashboard

SHIRE LLC v. MYLAN PHARMACEUTICALS, INC. (D.N.J. 2012)

Docket   Start Trial Date Filed 2012-02-02
Court District Court, D. New Jersey Date Terminated 2012-06-28
Cause 35:271 Patent Infringement Assigned To Stanley R. Chesler
Jury Demand None Referred To Michael Andre Shipp
Parties JOHNSON MATTHEY INC.; JOHNSON MATTHEY PHARMACEUTICAL MATERIALS; MYLAN INC.; MYLAN PHARMACEUTICALS, INC.; SHIRE DEVELOPMENT INC.; SHIRE LLC
Patents 7,105,486; 7,223,735; 7,655,630; 7,659,253; 7,659,254; 7,662,787; 7,671,030; 7,671,031; 7,674,774; 7,678,770; 7,678,771; 7,687,466; 7,687,467; 7,700,561; 7,718,619; 7,723,305
Attorneys LISA H. WANG; MICHAEL R. GRIFFINGER
Link to Docket External link to docket
Small Molecule Drugs cited in SHIRE LLC v. MYLAN PHARMACEUTICALS, INC.
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for SHIRE LLC v. MYLAN PHARMACEUTICALS, INC. (D.N.J. 2012)

Date Filed Document No. Description Snippet Link To Document
2012-02-02 1 Complaint Code, involving United States Patent No. 7,105,486 (“the ’486 patent”) (attached as Exhibit A hereto…486 patent, the ’735 patent, the ’630 patent, the ’253 patent, the ’254 patent, the ’787 patent, the…030 patent, the ’031 patent, the ’774 patent, the ’770 patent, the ’771 patent, the ’466 patent, the…486 patent, the ’735 patent, the ’630 patent, the ’253 patent, the ’254 patent, the ’787 patent, the …’030 patent, the ’031 patent, the ’774 patent, the ’770 patent, the ’771 patent, the ’466 patent, the External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
McKesson
Moodys
Baxter
Medtronic
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.